|
Low-Intensity Ultrasound for Treating Tumor Vasculature
|
1R43CA139657-01
|
$145,340
|
$145,340
|
Wood, Andrew
|
ACOUSTIC THERAPEUTICS
|
|
A Pb-212 Generator Using Resistant Substrate and Rn Cold Trapping
|
1R41CA135857-01A1
|
$111,339
|
$111,339
|
Ehrhardt, Gary
|
ALPHAMED, INC
|
|
Production and use of Pb-203 for cancer therapy research
|
5R44CA114920-03
|
$356,872
|
$356,872
|
MOORE, HERBERT
|
ALPHAMED, INC
|
|
Bifunctional T cell receptor based immunotherapeutics
|
2R44CA097550-05A1
|
$1,000,000
|
$250,000
|
WONG, HING
|
ALTOR BIOSCIENCE CORPORATION
|
|
MicroRNA Markers of Melanoma Metastasis in Lymph Nodes
|
1R43CA139700-01
|
$256,920
|
$256,920
|
Beaudenon, Sylvie
|
AMBION DIAGNOSTICS, INC.
|
|
Community Clinical Oncology Program Research Base
|
3U10CA037422-22S1
|
$26,578
|
$266
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-22
|
$1,683,081
|
$16,831
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
American College of Radiology Imaging Network
|
5U01CA080098-11
|
$8,896,390
|
$444,820
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-20
|
$521,201
|
$5,212
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
MOLECULAR DETERMINANTS OF BRAIN-METASTATIC MELANOMA
|
5R01CA086832-07
|
$279,192
|
$279,192
|
MARCHETTI, DARIO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Repression by C SKI and Melanoma Progression
|
5R01CA084282-09
|
$264,568
|
$264,568
|
MEDRANO, ESTELA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S1
|
$117,279
|
$2,346
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S2
|
$245,600
|
$4,912
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-03
|
$1,515,000
|
$30,300
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Antigen specificity, suppressive mechanism & regulation of CD4+ regulatory T cell
|
5R01CA116408-04
|
$258,529
|
$258,529
|
Wang, Rongfu
|
BAYLOR COLLEGE OF MEDICINE
|
|
Improving the Efficacy of Dendritic Cell Vaccines
|
3P01CA084512-07S1
|
$200,000
|
$160,000
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
Diversification of Cytotoxic Effector Cells Via LPS-activated DCs
|
5R01CA129350-02
|
$546,210
|
$546,210
|
PALUCKA, ANNA KAROLINA
|
BAYLOR RESEARCH INSTITUTE
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-26
|
$430,954
|
$4,310
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Rectifying defects in tumor vasculature to improve chemo- and radiation therapies
|
5R01CA129339-02
|
$352,750
|
$88,188
|
SENGER, DONALD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
The role of endothelial to mesenchymal transition (EndMT) in the tumor stroma
|
5K08CA129204-02
|
$135,270
|
$67,635
|
ZEISBERG, ELISABETH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Orphan Nuclear Receptor TR3 in tumor angiogenesis and associated microvessel perm
|
1R01CA133235-01A2
|
$352,750
|
$352,750
|
ZENG, HUIYAN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Regulation of LKB1 and AMPK Signaling by BRAF in Melanoma
|
5K99CA133245-02
|
$132,030
|
$132,030
|
Zheng, Bin
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Applying nanosecond pulse electric fields to treat skin cancer
|
5R01CA125722-02
|
$409,354
|
$204,677
|
NUCCITELLI, RICHARD
|
BIOELECTROMED CORPORATION
|
|
Ras Oncoprotein-Targeted Therapy for Cancer
|
3R01CA112102-05S1
|
$56,604
|
$28,302
|
Faller, Douglas
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Ras Oncoprotein-Targeted Therapy for Cancer
|
5R01CA112102-05
|
$302,435
|
$151,218
|
Faller, Douglas
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Melanoma Stem Cells, Vasculogenesis and Neoplastic Progression
|
5R01CA138231-02
|
$327,598
|
$327,598
|
Frank, Markus
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cohort Study of Genetic Susceptibility to Cutaneous Malignant Melanoma
|
5R01CA122838-02
|
$360,731
|
$360,731
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Prospective study of telomere length and melanoma risk
|
5R03CA133914-02
|
$87,608
|
$87,608
|
HAN, JIALI
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
SPORE in Skin Cancer
|
5P50CA093683-07
|
$2,300,000
|
$1,840,000
|
KUPPER, THOMAS
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Variants in MicroRNA-Related Genes and Skin Cancer Risk
|
1R03CA139496-01
|
$88,500
|
$44,250
|
Nan, Hongmei
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic Variants in Mitochondrial Genome and Skin Cancer Risk
|
1R03CA141606-01
|
$88,750
|
$22,188
|
Nan, Hongmei
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Population-Based Approach to Skin Cancer Epidemiology
|
5K07CA108978-04
|
$111,854
|
$39,149
|
QURESHI, ABRAR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Targeting Pten - An Upstream, Downstream and Offstream Approach
|
1P01CA128814-01A2
|
$2,124,342
|
$2,124,342
|
RONAI, ZE'EV
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Function of ATF2 URE Binding Protein in Human Melanoma
|
5R01CA051995-18
|
$369,117
|
$369,117
|
RONAI, ZE'EV
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
ATF2 in DNA damage response.
|
5R01CA117927-04
|
$463,878
|
$231,939
|
RONAI, ZE'EV
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Characterization of JNK in Cell Cycle Control
|
5R01CA138143-02
|
$396,325
|
$198,163
|
RONAI, ZE'EV
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA030199-28S1
|
$118,420
|
$7,105
|
VUORI, KRISTIINA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA030199-28S2
|
$3,387,817
|
$203,269
|
VUORI, KRISTIINA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
NanoSystems Biology Cancer Center
|
5U54CA119347-05
|
$3,644,422
|
$364,442
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-26
|
$841,092
|
$8,411
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
Molecular studies of T cell clones for adoptive therapy
|
5K23CA109115-04
|
$134,460
|
$67,230
|
Kim, Julian
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cedar Rapids Oncology Project
|
5U10CA052352-20
|
$446,062
|
$4,461
|
WIESENFELD, MARTIN
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
Semaphorin 3F: Structure, Function, and Anti-Metastatic Activity
|
5K01CA118732-04
|
$159,300
|
$79,650
|
BIELENBERG, DIANE
|
CHILDREN'S HOSPITAL BOSTON
|
|
ABCB5 P-Glycoprotein in Cancer Multidrug Resistance
|
5R01CA113796-04
|
$291,276
|
$291,276
|
Frank, Markus
|
CHILDREN'S HOSPITAL BOSTON
|
|
Cancer Biology in the Zebrafish
|
5R01CA103846-07
|
$369,046
|
$184,523
|
ZON, LEONARD
|
CHILDREN'S HOSPITAL BOSTON
|
|
Epigenetic Effect of the Microenvironment on Stem Cell Plasticity and Function
|
5R01CA121205-03
|
$330,969
|
$330,969
|
HENDRIX, MARY
|
CHILDREN'S MEMORIAL HOSPITAL (CHICAGO)
|
|
Endothelial Transdifferentiation of Invasive Tumor Cells
|
5R37CA059702-17
|
$393,942
|
$393,942
|
HENDRIX, MARY
|
CHILDREN'S MEMORIAL HOSPITAL (CHICAGO)
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-23
|
$1,282,700
|
$12,827
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
|
1K05CA136967-01A1
|
$131,592
|
$6,580
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Inhibitors in Src Signaling for Antitumor Therapy
|
5R01CA115674-03
|
$288,990
|
$144,495
|
Jove, Richard
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
Total relevant funding to Melanoma for this search: $103,671,511
|